B lymphocyte cytokines and rheumatic autoimmune disease

Arthritis and Rheumatism

Volumn 60, Issue 7, 2009, Pages 1873-1880

  Youinou, Pierre ^a,c   Taher, Taher E ^b   Pers, Jacques Olivier ^a   Mageed, Rizgar A ^b   Renaudineau, Yves ^a  

^a UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^b Universite de Brest   (France)

^c BREST UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; AUTOANTIBODY; B CELL ACTIVATING FACTOR; B LYMPHOCYTE RECEPTOR; CD3 ANTIGEN; CD5 ANTIGEN; CD79B ANTIGEN; CHEMOKINE RECEPTOR CXCR5; COLONY STIMULATING FACTOR 1; CXCL13 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; LYMPHOTOXIN; STAT1 PROTEIN; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CYTOKINE PRODUCTION; DISEASE SEVERITY; EFFECTOR CELL; GERMINAL CENTER; HELPER CELL; HUMAN; IMMUNOREGULATION; LYMPHOCYTIC INFILTRATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; TH1 CELL; TH2 CELL;

ANIMALS; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; RHEUMATIC DISEASES; SJOGREN'S SYNDROME;

EID: 67650094924     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24665     Document Type: Review

References (50)

1. Edwards JC, Cambridge G. Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes. Rheumatology (Oxford) 2001;40:205-11.
2. Eisenberg R, Albert D. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus. Nat Clin Pract Rheumatol 2006;2:20-7.
3. Teng YK, Levarht EW, Hashemi M, Bajema IM, Toes RE, Huizinga TW, et al. Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment. Arthritis Rheum 2007;56:3909-18.
4. Dass S, Rawstron AC, Vital EM, Henshaw K, McGonagle D, Emery P. Highly sensitive B cell analysis predicts response to rituximab therapy in rheumatoid arthritis. Arthritis Rheum 2008;58:2993-9.
5. Hamel K, Doodes P, Cao Y, Wang Y, Martinson J, Dunn R, et al. Suppression of proteoglycan-induced arthritis by anti-CD20 B cell depletion therapy is mediated by reduction in autoantibodies and CD4+ T cell reactivity. J Immunol 2008;180:4994-5003.
6. Chan OT, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 1999;189:1639-48.
7. Raza K, Falciani F, Curnow SJ, Ross EJ, Lee CY, Akbar AN, et al. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther 2005;7:R784-95.
8. Mitsias DI, Tzioufas AG, Veiopoulou C, Zintzaras E, Tassios IK, Kogopoulou O, et al. The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjögren's syndrome. Clin Exp Immunol 2002;128:562-8.
9. Klinman DM, Steinberg AD. Inquiry into murine and human lupus. Immunol Rev 1995;144:157-93.
10. Garrett-Sinha LA, John S, Gaffen SL. IL-17 and the Th17 lineage in systemic lupus erythematosus. Curr Opin Rheumatol 2008;20:519-25.
11. Harris DP, Haynes L, Sayles PC, Duso DK, Eaton SM, Lepak NM, et al. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol 2000;1:475-82.
12. Harris DP, Goodrich S, Gerth AJ, Peng SL, Lund FE. Regulation of IFN-γ production by B effector 1 cells: essential roles for T-bet and the IFN-γ receptor. J Immunol 2005;174:6781-90.
13. Johansson-Lindbom B, Borrebaeck CA. Germinal center B cells constitute a predominant physiological source of IL-4: implication for Th2 development in vivo. J Immunol 2002;168:3165-72.
14. Harris DP, Goodrich S, Mohrs K, Mohrs M, Lund FE. The development of IL-4-producing B cells is controlled by IL-4, IL-4 receptor α, and Th2 cells. J Immunol 2005;175:7103-7.
15. Chan RW, Lai FM, Li EK, Tam LS, Chow KM, Li PK, et al. Imbalance of Th1/Th2 transcription factors in patients with lupus nephritis. Rheumatology (Oxford) 2006;45:951-7.
16. Durali D, de Goer de Herve MG, Giron-Michel J, Azzarone B, Delfraissy JF, Taoufik Y, et al. In human B cells, IL-12 triggers a cascade of molecular events similar to Th1 commitment. Blood 2003;102:4084-9.
17. Menard LC, Minns LA, Darche S, Mielcarz DW, Foureau DM, Roos D, et al. B cells amplify IFN-γ production by T cells via a TNF-α-mediated mechanism. J Immunol 2007;179:4857-66.
18. Amel Kashipaz MR, Huggins ML, Lanyon P, Robins A, Powell RJ, Todd I. Assessment of Be1 and Be2 cells in systemic lupus erythematosus indicates elevated IL-10 producing CD5+ B cells. Lupus 2003;12:356-63.
19. Heine G, Sester U, Sester M, Scherberich JE, Girndt M, Kohler H. A shift in the Th1/Th2 ratio accompanies the clinical remission of systemic lupus erythematosus in patients with end-stage renal disease. Nephrol Dial Transplant 2002;17:1790-4.
20. Daridon C, Guerrier T, Devauchelle V, Saraux A, Pers JO, Youinou P. Polarization of B effector cells in Sjögren's syndrome. Autoimmun Rev 2007;6:427-31.
21. Le Pottier L, Devauchelle V, Fautrel A, Daridon C, Saraux A, Youinou P, et al. Ectopic germinal centers are rare in Sjögren's syndrome salivary glands and do not exclude autoreactive B cells. J Immunol 2009;182:3540-7.
22. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor directs Th1 lineage commitment. Cell 2000;100:655-69.
23. Peng SL, Szabo SJ, Glimcher LH. T-bet regulates IgG class switching and pathogenic autoantibody production. Proc Natl Acad Sci U S A 2002;99:5545-50.
24. Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997;89:587-96.
25. Kawashima M, Miossec P. mRNA quantification of T-bet, GATA-3, IFN-γ, and IL-4 shows a defective Th1 immune response in the peripheral blood from rheumatoid arthritis patients: link with disease activity. J Clin Immunol 2005;25:209-14.
26. Kawashima M, Miossec P. Effect of treatment of rheumatoid arthritis with infliximab on IFN-γ, IL-4, T-bet and GATA-3 expression: improvement of systemic inflammation and disease activity. Ann Rheum Dis 2005;64:415-8.
27. Stockinger B, Zal T, Zal A, Gray D. B cells solicit their own help from T cells. J Exp Med 1996;183:891-9.
28. Duddy M, Niino M, Adatia F, Hebert S, Freedman M, Atkins H, et al. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J Immunol 2007;178:6092-9.
29. Lopez C, Comabella M, Tintore M, Sastre-Garriga J, Montalban X. Variations in chemokine receptor and cytokine expression during pregnancy in multiple sclerosis patients. Mult Scler 2006;12:421-7.
30. Mackay F, Schneider P, Rennert P, Browning J. BAFF AND APRIL: a tutorial on B-cell survival. Annu Rev Immunol 2003;21:231-64.
31. Thien M, Phan TG, Gardam S, AmesburyM, Basten A, Mackay F, et al. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 2004;20:785-98.
32. Sutherland AP, Ng LG, Fletcher CA, Shum B, Newton RA, Grey ST, et al. BAFF augments certain Th1-associated inflammatory responses. J Immunol 2005;174:5537-44.
33. + T cells in BAFF-transgenic mice suppress T cell effector responses. J Immunol 2009;182:793-801.
34. Ohata J, Zvaifler NJ, Nishio M, Boyle DL, Kalled SL, Carson DA, et al. Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines. J Immunol 2005;174:864-70.
35. Daridon C, Youinou P, Pers JO. BAFF, APRIL, TWE-PRIL: who's who? Autoimmun Rev 2008;7:267-71.
36. Bosello S, Youinou P, Daridon C, Tolusso B, Bendaoud B, Pietrapertosa D, et al. Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis. J Rheumatol 2008;35:1256-64.
37. Pers JO, d'Arbonneau F, Devauchelle-Pensec V, Saraux A, Pennec YL, Youinou P. Is periodontal disease mediated by salivary BAFF in Sjögren's syndrome? Arthritis Rheum 2005;52:2411-4.
38. Zhang J, Roschke V, Baker KP, Wang Z, Alarcon GS, Fessler BJ, et al. Cutting edge: a role for BLyS in systemic lupus erythematosus. J Immunol 2001;166:6-10.
39. Novak AJ, Bram RJ, Kay NE, Jelinek DF. Aberrant expression of BLyS by B chronic lymphocytic leukemia cells: a mechanism for survival. Blood 2002;100:2973-9.
40. Daridon C, Devauchelle V, Hutin P, Le Berre R, Martins-Carvalho C, Bendaoud B, et al. Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum 2007;56:1134-44.
41. Nishimoto N, Kishimoto T. IL-6: from bench to bedside. Nat Clin Pract Rheumatol 2006;2:619-26.
42. Nagafuchi H, Suzuki N, Mizushima Y, Sakane T. Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus. J Immunol 1993;151:6525-34.
43. Hillion S, Dueymes M, Youinou P, Jamin C. IL-6 contributes to the expression of RAGs in human mature B cells. J Immunol 2007;179:6790-8.
44. Kitani A, Hara M, Hirose T, Harigai M, Suzuki K, Kawakami M, et al. Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression. Clin Exp Immunol 1992;88:75-83.
45. Klein U, Dalla-Favera R. Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 2008;8:22-33.
46. Hsu HC, Yang P, Wang J, Wu Q, Myers R, Chen J, et al. IL-17 producing T helper cells and IL-17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 2008;9:166-75.
47. Jamin C, Morva A, Lemoine S, Daridon C, Revol de Mendoza A, Youinou P. Regulatory B lymphocytes in humans: a potential role in autoimmunity [review]. Arthritis Rheum 2008;58:1900-6.
48. Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W, Garnier S, et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 2008;358:900-9.
49. Kozyrev SV, Abelson AK, Wojcik J, Zaghlool A, Linga Reddy MV, Sanchez E, et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet 2008;40:211-6.
50. Garaud S, Le Dantec C, Jousse S, Hanrotel C, Saraux A, Mageed RA, et al. IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation. J Immunol 2009;182:5623-32.